Iterum Therapeutics plc Board of Directors

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Mr. Corey N. Fishman

Mr. Corey N. Fishman

President, CEO & Director

Dr. Steven I. Aronin M.D.

Dr. Steven I. Aronin M.D.

Senior VP & Head of Clinical Development

Ms. Judith M. Matthews

Ms. Judith M. Matthews

Chief Financial Officer

Ms. Louise Barrett

Ms. Louise Barrett

Senior Vice President of Legal Affairs & Secretary

Dr. Michael W. Dunne M.D.

Dr. Michael W. Dunne M.D.

Strategic Advisor & Director

Mr. Tom Loughman Ph.D.

Mr. Tom Loughman Ph.D.

Senior Vice President of Technical Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.